Kelly RJ - Search Results

1

International Perspective on the Pursuit of Quality in Cancer Care: Global Application of QOPI and QOPI Certification.

Blayney DW, Albdelhafeez N, Jazieh AR, Pinto CF, Udrea A, Roach A, Das D, Grubbs S, Hamm J, Jahanzeb M, Kamal AH, Kelly RJ, Martin SE, O'Mahony D, Birch W, Bowman R, Crist STS, Evers A, Gilmore T, Klein M, Siegel R. Blayney DW, et al. Among authors: kelly rj. JCO Glob Oncol. 2020 May;6:697-703. doi: 10.1200/GO.20.00048. JCO Glob Oncol. 2020. PMID: 32374622 Free PMC article. No abstract available.

2

Recent advances in immune-based approaches for the treatment of esophagogastric cancer.

Weadick CS, Duffy AG, Kelly RJ. Weadick CS, et al. Among authors: kelly rj. Expert Opin Emerg Drugs. 2022 Mar;27(1):19-31. doi: 10.1080/14728214.2021.2020757. Epub 2022 Jan 3. Expert Opin Emerg Drugs. 2022. PMID: 34937483

3

Patients and Physicians Can Discuss Costs of Cancer Treatment in the Clinic.

Kelly RJ, Forde PM, Elnahal SM, Forastiere AA, Rosner GL, Smith TJ. Kelly RJ, et al. J Oncol Pract. 2015 Jul;11(4):308-12. doi: 10.1200/JOP.2015.003780. Epub 2015 May 26. J Oncol Pract. 2015. PMID: 26015459 Free PMC article.

4

The emerging role of immunotherapy for esophageal cancer.

Kelly RJ. Kelly RJ. Curr Opin Gastroenterol. 2019 Jul;35(4):337-343. doi: 10.1097/MOG.0000000000000542. Curr Opin Gastroenterol. 2019. PMID: 31045596 Review.

5

Challenges, Perceptions, and Readiness of Oncology Clinicians for the MACRA Quality Payment Program.

Nabhan C, Jeune-Smith Y, Klinefelter P, Kelly RJ, Feinberg BA. Nabhan C, et al. Among authors: kelly rj. JAMA Oncol. 2018 Feb 1;4(2):252-253. doi: 10.1001/jamaoncol.2017.3773. JAMA Oncol. 2018. PMID: 29167859 Free PMC article.

6

Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.

Catenacci DVT, Kang YK, Park H, Uronis HE, Lee KW, Ng MCH, Enzinger PC, Park SH, Gold PJ, Lacy J, Hochster HS, Oh SC, Kim YH, Marrone KA, Kelly RJ, Juergens RA, Kim JG, Bendell JC, Alcindor T, Sym SJ, Song EK, Chee CE, Chao Y, Kim S, Lockhart AC, Knutson KL, Yen J, Franovic A, Nordstrom JL, Li D, Wigginton J, Davidson-Moncada JK, Rosales MK, Bang YJ; CP-MGAH22-5 Study Group. Catenacci DVT, et al. Among authors: kelly rj. Lancet Oncol. 2020 Aug;21(8):1066-1076. doi: 10.1016/S1470-2045(20)30326-0. Epub 2020 Jul 9. Lancet Oncol. 2020. PMID: 32653053 Clinical Trial.

7

Emerging Multimodality Approaches to Treat Localized Esophageal Cancer.

Kelly RJ. Kelly RJ. J Natl Compr Canc Netw. 2019 Aug 1;17(8):1009-1014. doi: 10.6004/jnccn.2019.7337. J Natl Compr Canc Netw. 2019. PMID: 31390584 Review.

8

Considerations in the Care of Non-Small-Cell Lung Cancer: The Value Imperative.

Kelly R, Houseknecht S. Kelly R, et al. Oncology (Williston Park). 2018 Nov 15;32(11):534-40. Oncology (Williston Park). 2018. PMID: 30474101 Review.

9

The role of talactoferrin alpha in the treatment of non-small cell lung cancer.

Kelly RJ, Giaccone G. Kelly RJ, et al. Expert Opin Biol Ther. 2010 Sep;10(9):1379-86. doi: 10.1517/14712598.2010.512914. Expert Opin Biol Ther. 2010. PMID: 20684737 Free PMC article. Review.

10

Personalizing therapy in an epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer using PF-00299804 and trastuzumab.

Kelly RJ, Carter C, Giaccone G. Kelly RJ, et al. J Clin Oncol. 2010 Oct 1;28(28):e507-10. doi: 10.1200/JCO.2010.29.3126. Epub 2010 Aug 2. J Clin Oncol. 2010. PMID: 20679607 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page